Aron Tendler
Chief Tech/Sci/R&D Officer at BRAINSWAY LTD.
Aron Tendler active positions
Companies | Position | Start | End |
---|---|---|---|
BRAINSWAY LTD. | Chief Tech/Sci/R&D Officer | 30/09/2015 | - |
Graymatters Health
Graymatters Health Medical/Nursing ServicesHealth Services Graymatters Health develops self-neuromodulation therapies for mental health care. Graymatters Health is based in Haifa, Israel. The Israeli company is the first to develop a treatment based on digital biomarkers of brain-mechanism-specific activity associated with mental disorders. The company's flagship FDA-cleared product, Prism for PTSD, is an award-winning digital therapy that uses advanced statistical models to register fMRI data with an accessible and low-cost modality, EEG. The company's products use these biomarkers with an interactive simulation to help patients regain control over the relevant brain activity. Graymatters Health is collaborating with leading mental health institutions to evaluate Prism for additional mental disorders. The company was founded by Rani Cohen, Oded Kraft, Shai Attia, and Oded Kraft has been the CEO since incorporation. | Corporate Officer/Principal | 25/09/2023 | - |
Career history of Aron Tendler
Former positions of Aron Tendler
Companies | Position | Start | End |
---|---|---|---|
Advanced Mental Health Care, Inc. | Founder | 31/12/2005 | - |
Training of Aron Tendler
State University of New York at Downstate Medical Center | Undergraduate Degree |
Statistics
International
Israel | 3 |
United States | 3 |
Operational
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Founder | 1 |
Sectoral
Health Technology | 2 |
Consumer Services | 2 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
BRAINSWAY LTD. | Health Technology |
Private companies | 2 |
---|---|
Advanced Mental Health Care, Inc. | |
Graymatters Health
Graymatters Health Medical/Nursing ServicesHealth Services Graymatters Health develops self-neuromodulation therapies for mental health care. Graymatters Health is based in Haifa, Israel. The Israeli company is the first to develop a treatment based on digital biomarkers of brain-mechanism-specific activity associated with mental disorders. The company's flagship FDA-cleared product, Prism for PTSD, is an award-winning digital therapy that uses advanced statistical models to register fMRI data with an accessible and low-cost modality, EEG. The company's products use these biomarkers with an interactive simulation to help patients regain control over the relevant brain activity. Graymatters Health is collaborating with leading mental health institutions to evaluate Prism for additional mental disorders. The company was founded by Rani Cohen, Oded Kraft, Shai Attia, and Oded Kraft has been the CEO since incorporation. | Health Services |
- Stock Market
- Insiders
- Aron Tendler
- Experience